As typical tumor suppressor genes (TSGs), the cyclin‐dependent kinase inhibitors CDKN2A and CDKN2B located on chromosome 9, band p21.3, are frequently mutated, deleted, or dysregulated in a variety of cancers [1, 2, 3, 4, 5]. Here, CDKN2B is linked to cancer.